Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Spectranetics wins clearance for new Cross-Pilot catheter
The Cross-Pilot is a laser support catheter for the 0.9 Turbo Elite laser ablation catheter. The Cross-Pilot was designed to provide additional support for reaching distal lesions. The
The Cross-Pilot is a laser support catheter for the 0.9 Turbo Elite laser ablation catheter. The Cross-Pilot was designed to provide additional support for reaching distal lesions. The
The trial is planned to be a 28-day multi-center, randomized, double-blind, placebo controlled study to assess the efficacy of topical SYI-2074, applied twice daily, for the treatment of
The litigation related to a portfolio of patents that apply to stabilizing medical images for interventional procedures such as cardiac catheters and stents, and for diagnostics procedures such
Mr Gandolfo has over 21 years of experience as CFO of private and publicly held companies with a primary focus in the life sciences, healthcare and medical device
Life Technologies (formerly Invitrogen) was awarded a two-year grant of nearly $870,000. The company will focus on human embryonic stem cells to create the disease models and will
In this open-label Phase II trial, quarfloxin will be administered to patients with low or intermediate grade carcinoid/neuroendocrine tumors (C/NET), including those receiving concomitant treatment with a stable
In conjunction with Dr Laikind’s resignation, the company has appointed Mark Erion, chief scientific officer and executive vice president of R&D and a member of Metabasis board of
The Phase I study was a single-center, double-blind, placebo-controlled crossover study with an open-label positive control arm to investigate the pharmacokinetic and pharmacodynamic profile of single oral doses
After review of the collected data, the independent data monitoring committee did not identify any safety concerns and has recommended that the trial continue per the protocol. This
Medidur is a tiny intravitreal insert designed to be administered by an eye care professional, using a proprietary 25-gauge inserter in a minimally invasive, outpatient procedure. This application